Some authors suggest that within the pancreas, where KRAS mutation alone is insufficient to initiate an invasive carcinoma, the synergistic effect of microbe-induced inflammation and KRAS mutation could sustain the tumorigenic process [60]. The gene discussed is KRAS; the disease is invasive carcinoma.